AKT1 and hepatocellular carcinoma: Simultaneous inhibition of PI3K/AKT/mTOR and DNA damage repair pathways can enhance the chemotherapy sensitivity of HCC to platinum drugs (such as oxaliplatin), through a mechanism like that of radiation [28].